Arthritis and rheumatology

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

US

tipo

journal

publicação venue de

Anti-NET antibodies in antiphospholipid antibody-positive patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository. .:1-20. 2023-01-01
Fluctuation of 1 and Glycoprotein I Antibody Titers Over Time in Patients with Persistently Positive Antiphospholipid Antibodies. 0(0):1. 2023-01-01
High TNFAIP3-Transfected Cell Activity: An In Vitro Model for Phagocyte Study of Monogenic Behcet's Disease Pathophysiology. 74:3384. 2022-01-01
Phase / , Randomized, -Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus. 74:112-123. 2022-01-01
Additional points to consider before incorporating the Food and Drug Administration-approved therapies for systemic sclerosis-associated interstitial lung disease. 999:999. 2021-01-01
Association of Bone Erosions and Osteophytes With Systemic Bone Involvement on High¿Resolution Peripheral Quantitative Computed Tomography in Premenopausal Women With Longstanding Rheumatoid Arthritis. 74:407-417. 2021-01-01
Clinical and methodological considerations on the results of the SENSCIS trial: Comment on the article by Maher et al.. 999:art.41893. 2021-01-01
Efficacy, Safety, and Pharmacodynamic Effects of the Bruton?s Tyrosine Kinase Inhibitor, Fenebrutinib (GDC-0853), in Systemic Lupus Erythematosus. 1:art.41811-10. 2021-01-01
Eosinophil ETosis-mediated release of galectin-10 in eosinophilic granulomatosis with polyangiitis. 73:art.41727. 2021-01-01
International Consensus for the Dosing of Corticosteroids in Childhood-Onset Systemic Lupus Erythematosus With Proliferative Lupus Nephritis. 000:1-000. 2021-01-01
Does Leukopenia Influence Performance of the New European League Against Rheumatism/American College of Rheumatology Classification Criteria in an African-Descendent Population With Childhood-Onset Systemic Lupus Erythematosus? Comment on the Article by Aringer et al. 72:694-695. 2020-01-01
Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label 2-Year Extension of a Phase 3 Trial. 73:530. 2020-01-01
Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-naïve Patients with Moderately to Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Randomized, Double-blind, Active-comparator, Multi-center, Multi-country Trial. 1:art.41384-1. 2020-01-01
Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double-Blind, Phase Trial. 72:1435-1446. 2020-01-01
Sepiapterin Reductase Inhibition Leading to Selective Reduction of Inflammatory Joint Pain in Mice and Increased Urinary Sepiapterin Levels in Humans and Mice. 72:57-66. 2020-01-01

tem uma área de assunto

publisher

Wiley-Blackwell

is open access

False invalid format

is in DOAJ

False invalid format